                                                                                                1                                                
    KULLANMA TAL √∏MATI 
/$)/(.6√∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ 
'DPDULoLQHX\JXODQ√ïU 
Steril.
Etkin maddeler: Her bir litre √ß√∂zelti 45.44 gram dekstroz anhidrit (50 g dekstroz m onohidrata 
H√∫GH√∑HU 2.6 gram sodyum laktat, 1.3 gram potasyum klor√ºr, 0.31 gram magnezyum klor √ºr 
hekzahidrat ve 0.26 gram dibazik potasyum fosfat i√ßerir. (OHNWUROLW NRQVDQWUDV\RQODU√ï P(T/ 
(mmol/L): Sodyum 25 (25), Klor 20.5 (20.5), Potasyum 20.4 (20.4), Magnezyum 3 (1.5), La ktat 23 
(23), Fosfat 3 (1,5).
<DUG√ïPF√ï PDGGHOHU Sodyum bis√ºlfit (E222), hidroklorik asit S+ D\DUODPDN LoLQ NXOODQ√ïO√ïU , steril 
enjeksiyonluk su.
%X LODF√ï NXOODQPD\D ED √∫lamadan √∂nce bu KULLANMA TALIMATINI dikkatlice okuyunuz, 
√ß√ºnk√º sizin i√ßin √∂nemli bilgiler i√ßermektedir. 
‚Ä¢%XNXOODQPDWDOLPDW√ïQ√ïVDNOD\√ïQ√ï]'DKDVRQUDWHNUDURNXPD\DLKWL\DoGX\DELOLUVLQL] 
‚Ä¢E√∑HULODYHVRUXODU√ïQ√ï]ROXUVDO¬ÅWIHQGRNWRUXQX]DYH\DHF]DF√ïQ√ï]DGDQ√ï √∫√ïQ√ï] 
‚Ä¢Bu ila√ß ki √∫isel olarak sizin i√ßin re√ßete edilmi √∫tir, ba √∫NDODU√ïQDYHUPH\LQL] 
‚Ä¢%X LODF√ïQ NXOODQ√ïP√ï V√ïUDV√ïQGD GRNWRUD YH\D KDVWDQH\H JLWWL √∑LQL]GH GRNWRUXQX]D EX LODF√ï 
NXOODQG√ï √∑√ïQ√ï]√ïV|\OH\LQL] 
‚Ä¢%X WDOLPDWWD \D]√ïODQODUD D\QHQ X\XQX] √∏ODo KDNN√ïQGD VL]H |QHULOHQ GR]XQ G√ï √∫√ïQGD y√ºksek veya 
d√º √∫√ºk doz NXOODQPD\√ïQ√ï] 
%X.XOODQPD7DOLPDW√ïQGD 
1. /$)/(.6√∏=2/√∏)( -3'(.6752=dg=(/7√∏6√∏QHGLUYHQHLoLQNXOODQ√ïO√ïU" 
2. LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ QL kullanmadan √∂nce dikkat edilmesi 
gerekenler 
3. /$)/(.6√∏=2/√∏)( -3'(.6752=dg=(/7√∏6√∏QDV√ïO NXOODQ√ïO√ïU" 
2ODV√ï\DQHWNLOHUQHOHUGLU" 
5. LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏¬∂QLQVDNODQPDV√ï 
Ba √∫O√ïNODU√ï\HUDOPDNWDG√ïU 
1. LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ QHGLUYHQHLoLQNXOODQ√ïO√ïU" 
LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ v√ºcudun VXVX] YH WX]VX] NDOPDV√ï 
GHKLGUDWDV\RQ GXUXPXQXQ WHGDYLVLQGH YH EX GXUXPXQ ROX√∫PDV√ïQ√ï |QOHPHN LoLQ NXOOD Q√ïODQ YH 
damar i√ßi yoldan uygulanan bir √ß√∂zeltidir. 
9¬ÅFXWWDQND\EHGLOHQV√ïY√ïQ√ïQYHHOHNWUROLWDG√ïYHULOHQED]√ïPDGGHOHULQ \HULQHNRQPDV√ïQGDL√∫ e yarar ve 
ELUPLNWDUNDORULVD√∑ODU 
LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ 250, 500 ve 1000 mililitre hacminde plastik 
WRUEDODUGDVXQXOPX√∫WXU6HWOLYHVHWVL]LNLIRUPXEXOXQPDNWDG√ïU                                                                                                 2                                                
    LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6 √∏i√ßerisinde v√ºcut i√ßin gerekli olan elementler 
\DS√ïWD√∫ODU√ïLoHUHQELUo|]HOWLGLU 
√∏oHUGL√∑LJOXNR]√∫HNHUVD\HVLQGHELUPLNWDUNDORULGHVD√∑ODU 
'DPDULoL\ROGDQNXOODQ√ïODQELUo|]HOWLGLU 
LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ √∂zellikle bebek ve k√º√ß√ºk √ßocuklarda g√ºnl√ºk 
V√ïY√ï -elektrolit dengesinin idamesinde, ani ba √∫OD\DQLVKDOOLoRFXNODUGDNLV√ïY√ïYHGL√∑HUND\√ïSODU√ïQ\HULQH 
NRQPDV√ïQGD YH HUL√∫NLQOHUGHNL D√∫√ïU√ï V√ïY√ï ND\√ïSODU√ïQ√ï \D GD √∫HNHU KD VWDO√ï√∑√ïQD ED√∑O√ï ED]√ï GXUXPODU√ïQ 
√∂nlenmesi ve tedavisinde tercih edilir. 
LAFLEKS √∏=2/√∏)( -P% 5 DEKSTRO = dg=(/7√∏6√∏ NRQVDQWUH IRUPGD EXOXQDQ ED]√ï GDPDU LoL 
X\JXODPD\D X\JXQ LODoODU√ïQ GDPDU LoLQH X\JXODQPDGDQ |QFH VH\UHOW LOPHVL DPDF√ï\OD GD 
NXOODQ√ïOPDNWDG√ïU 
2. LAFLEKS √∏=2/√∏)( -P kullanmadan √∂nce dikkat edilmesi gerekenler 
LAFLEKS √∏=2/√∏)( -P% 5 '(.6752= dg=(/7√∏6√∏ bir√ßok KDVWDGD HPQL\HWOL ELU LODoW√ïU $QFDN 
NDOELQL]E|EUHNOHULQL]NDUDFL√∑HULQL]YH\DDNFL√∑HUOHULQL]GHVRUXQODUYD UVD√∫HNHUKDVWDV√ï\VDQ√ï]\DGD 
Y¬ÅFXGXQX]GDD√∫√ïU√ïWX]ELULNLPLQHED√∑O√ï√∫L√∫OLNOHU|GHPYDUVDGRNWRUXQX]EXL ODF√ïVL]H uygulamamaya 
karar verebilir. 
LAFLEKS √∏=2/√∏)( -P   '(.6752= dg=(/7√∏6√∏ ‚Äôni a √∫a√∑√ïGDNL GXUXPODUGD 
KULLANMAYINIZ 
Daha √∂nce LAFLEKS √∏=2/√∏)( -PLoHUGL√∑LHWNLQPDGGHOHU\DGD\DUG√ïPF√ïPDGGHOHULLoHUHQL ODoODU√ï 
DOG√ï√∑√ïQ√ï]GDDOHUMLNELUWHSNLJ|VWHUGL\VHQL]\DQLVL]GHDQLGHQVRO XNNHVLOPHVLK√ïU√ïOW√ïO√ïVROXQXPGHUL 
d√∂k√ºnt√ºleri, ka √∫√ïQW√ï\DGDY¬ÅFXGXQX]GD√∫L√∫PHJLELEHOLUWLOHUROX√∫WX\VDEXLODF√ï .8//$10$<,1,= 
$OHUMLQL]ROXSROPDG√ï√∑√ïQGDQHPLQGH√∑LOVHQL]GRNWRUXQX]DGDQ√ï√∫√ïQ√ï] 
d|]HOWLD√∫D√∑√ïGDNLGXUXPODUGDNXOODQ√ïOPDPDO√ïG√ïU 
x√∏GUDU√ïQKLoROPDG√ï√∑√ï\DGDoRND]ROGX√∑XKDVWDODUDQ¬ÅULD√∑√ïUROLJ¬ÅULE|EUHN \HWPH]OL√∑L 
x6DYD√∫ODUND]DODUPDGHQOHUGHNLJ|o¬ÅNOHUHQG¬ÅVWULYHWUDILNND]DO DU√ïQGDY¬ÅFXWWDNLNDVNLWOHVLQLQ 
H]LOPHVL\OHRUWD\Do√ïNDQELUEHOLUWLN¬ÅPHVL&UXVKVHQGUR mu). 
x$O\XYDUODU√ïQGROD√∫√ïPLoLQGHSDUoDODQPDV√ïD√∑√ïUKHPROL]GXUXPODU√ï 
x%|EUHN¬ÅVW¬ÅEH]LQLQ\HWPH]OL√∑L 
xKandaki parat KRUPRQG¬Å]H\OHULQLQG¬Å√∫¬ÅNROGX√∑XGXUXPODUKLSRSDUDWLURLGL]P 
x%D]√ïNDOSKDVWDO√ïNODU√ïNDOSEORNX 
x.DQ√ïQQRUPDOS+¬∂V√ïQ√ïQED]LNWDUDIDND\P√ï√∫ROPDV√ïDONDOR] 
x6¬ÅOILWOHUHYHP√ïV√ïUND\QDNO√ï¬ÅU¬ÅQOHUHNDU√∫√ïD√∫√ïU√ïGX\DUO√ïO√ïNGXUXPXQGD 
LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏¬∂Q i a √∫a√∑√ïGDNL GXUXPODUGD '√∏ KKATL √∏
KULLANINIZ 
E√∑er sizde; 
xkDOSKDVWDO√ï√∑√ï|]HOOLNOHGHELUOLNWHELUE|EUHNKDVWDO√ï√∑√ïGD varsa); 
xdola√∫an kDQKDFPLQL]DUWP√ï√∫ sa (hipervolemi); 
xkalp yetmezli √∑L RODV√ïO√ï√∑√ï YH\D D√∫ ikar bir kalp yetmezli √∑L GXUXPXQX] YDUVD |]HOOLNOH GH 
DPHOL\DWWDQVRQUDNLG|QHPGHELUKDVWD\VDQ√ï]YH\D\D√∫O√ï\VDQ√ï]                                                                                                 3                                                
    xtansiyonunuz y√ºksekse; 
xY¬ÅFXGXQX]GDNROYHEDFDNODU√ïQ√ï]GD\DGDDNFL√∑HUOHULQL]GHVXWRSODQPDV√ï|GHPROPX√∫ sa; 
xb√∂brek i √∫levleriniz bozulmu √∫VD E|EUHNOHULQL] YH\D LGUDU \ROODU√ïQ√ï]GD WD√∫ vb nedenlerle bir 
W√ïNDQ√ïNO√ïNYDUVD 
xv√ºcutta potasyumun a √∫√ïU√ï ELULNLPLQH QHGHQ RODQ GXUXPODU YDUVD YH\D DQL JHOL√∫ en susuz kalma 
GXUXPX DNXW GHKLGUDWDV\RQ ED]√ï E|EUHN KDVWDO√ïNODU√ï YH FLGGL \DQ√ïN GXUXPO DU√ï JLEL v√ºcuttaki 
SRWDV\XPXQ\¬ÅNVHOPHVLQH\DWN√ïQO√ï√∑√ïDUWW√ïUDQGXUXPODUYDUVD 
x√∫HNHU KDVWDO√ï√∑√ïQ√ï] JL]OL √∫ ekeriniz ya da herhangi bir nedenle karbonhidratlara kar √∫√ï 
tahamm√ºls√ºzl√ºk durumunuz varsa; 
xv√ºcutta ger√ßekle √∫HQ \DS√ïP \√ïN√ïP ROD\ODU√ïQD \D GD VROXQXP KDVWDO√ï√∑√ïQD ED√∑O√ï RODUD N NDQ√ïQ√ï]√ïQ 
S+¬∂V√ïED]LNWDUDIDND\P√ï√∫ sa (metabolik ya da respiratuvar alkaloz); 
xkaraci √∑erinizde bir yetmezlik durumu varsa; 
doktorunuz size LAFLEKS √∏=2/√∏) E-P  '(.6752= dg=(/7√∏6√∏ ‚ÄônL NXOODQ√ïUNHQ |]HO GLNNDW 
g√∂sterecektir. 
+DOHQ GLMLWDO JUXEXQGDQ NDOS LODoODU√ï\OD WHGDYL J|U¬Å\RUVDQ√ï] WHGD YLQL] V√ïN V√ïN NDOS HOHNWURQX] 
oHNLOHUHN\DS√ïODFDNW√ïU 
$\U√ïFD ED]√ï QHGHQOHUOH VL]GH D√∫√ïU√ï ELU HOHNWUROLW ND\E√ï YDUVD GRN torunuz size bu ilaca ek olarak 
elektrolit uygulamak isteyecektir; bazen de tedavinize di √∑HU PLQHUDO YH YLWDPLQOHUL GH eklemek 
isteyebilir. 
%X LODo VL]H HOHNWURQLN ELU SRPSD DUDF√ïO√ï√∑√ï\OD X\JXODQDFDNVD WRU EDQ√ïQ W¬ÅP¬Å\OH ER√∫ almadan √∂nce 
SRPSDQ√ïQoDO√ï√∫PDV√ïQ√ïQ durmu √∫oldu √∑una dikkat edilmelidir. 
%XLODF√ïQVL]HX\JXODQ√ïUNHQNXOODQ√ïODQERUXODU√ïQVHWOHULQVDDWW HELUGH√∑ i√∫tirilmesi √∂nerilir. $\U√ïFD 
\DOQ√ï]FDWRUEDVD√∑ lamsa ve i√ßindeki √ß√∂ ]HOWLEHUUDNVDNXOODQ√ïOPDO√ïG√ïU 
LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏¬∂ nin \L\HFHNYHLoHFHNLOHNXOODQ√ïOPDV√ï 
LAFLEKS √∏=2/√∏)( -PGDPDU \ROX\OD X\JXODQDQ ELU LODoW√ïU X\JX lama √∫HNOL Do√ïV√ïQGDQ \L\HFHN YH 
i√ßeceklerle herhangi bir etkile √∫imi yoktur. 
Hamilelik 
√∏ODF√ïNXOODQPDGDQ|QFHGRNWRUXQX]D\DGDHF]DF√ïQ√ï]DGDQ√ï √∫√ïQ√ï] 
Doktorunuz WDUDI√ïQGDQ |]HOOLNOH X\JXQ J|U¬ÅOPHGL√∑ i takdirde, gebelik d√∂neminde LAFLEKS 
√∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ ‚ÄôniNXOODQPD\√ïQ√ï] 
7HGDYLQL]V√ïUDV√ïQGDKDPLOHROGX √∑unuzu fark ederseniz he PHQGRNWRUXQX]DYH\DHF]DF√ïQ√ï]DGDQ√ï √∫√ïQ√ï] 
Emzirme 
√∏ODF√ïNXOODQPDGDQ|QFHGRNWRUXQX]D\DGDHF]DF√ïQ√ï]DGDQ√ï √∫√ïQ√ï] 
Bebe √∑LQL]LHP]LUL\RUVDQ√ï]EXGXUXPXGRNWRUXQX]DELOGLULQL]'RNWRUXQX]WDUDI√ïQGDQ √∂zellikle uygun 
g√∂r√ºlmedi √∑i takdirde, emzirme d√∂neminde LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ ‚Äôni
NXOODQPD\√ïQ√ï] 
Ara√ß ve makine NXOODQ√ïP√ï 
LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ ‚Äônin DUDo \D GD PDNLQH NXOODQ√ïP√ï ¬Å]HULQGH 
herha QJLELUHWNLVLEXOXQPDPDNWDG√ïU                                                                                                 4                                                
    LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ ‚Äônin i√ßeri √∑LQGH EXOXQDQ ED]√ï \DUG√ïPF√ï 
PDGGHOHUKDNN√ïQGD|QHPOLELOJLOHU 
%XW√ïEEL¬ÅU¬ÅQ her 100 ml‚Äôsinde 21 mg E222 Sodyum bis√ºlfit i√ßermektedir. Parenteral yolla DO√ïQG√ï√∑√ïQGD 
QDGLURODUDN√∫LGGHWOLD√∫√ïU√ïGX\DUO√ïNUHDNVL\RQODU√ïQDYHEURQNRVSD]PDQHGHQRODELOLU 
Di √∑HULODoODULOHELUOLNWHNXOODQ√ïP√ï 
5HoHWHVL]DO√ïQDQLODoODUD√∫√ïODUYHELWNLVHOLODoODUGDGDKL OROPDN¬Å]HUHED√∫NDKHUKDQJLELULODoDOPD\√ï 
SODQO√ï\RUVDQ√ï]DO√ï\RUVDQ√ï]YH\D\DN√ïQ]DPDQGDDOG√ï\VDQ√ï]O¬ÅWIHQGRNWRUXQX]D bildiriniz. 
LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ ED]√ï LODoODUOD JHoLPVL]GLU *HoLPVL] ROGX√∑X 
bilinen bu ila√ßlar √ß√∂zeltiye HNOHQPHPHOL EX LODoODU√ïQ VH\UHOWLOPHVL LoLQ ED√∫ ka √ß√∂zeltiler tercih 
edilmelidir. 
√á√∂zeltiye eklenecek herhangi ba √∫ka bir ila√ßla olabilecek bir ge√ßimsizlik riskini en aza indi rmek i√ßin, 
NDU√ï√∫W√ïUPD L√∫ leminden hemen sonra, uygulamadan |QFH YH X\JXODPD V√ïUDV√ïQGD belirli aralarla 
X\JXODPDV√ï \DS√ïODFDN VRQ NDU√ï√∫√ïPGD KHUKDQJL ELU EXODQ√ïNO√ïN YH\ a √ß√∂kelme olup ROPDG√ï√∑√ï VD√∑O√ïN 
J|UHYOLVLWDUDI√ïQGDQNRQWUROHGLOHFHNWLU 
$\U√ïFD LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ ile a √∫a√∑√ïGDNL LODoODU√ïQ ELU arada 
NXOODQ√ïP√ïV√ïUDV√ïQGDEXLODoODU√ïQHWNLOHULGLNNDWHDO√ïQPDO√ïG√ïU 
xKortikoidler/steroidler ve karbenoksolon (v√ºcutta sodyum ve su birikmesi riski nede niyle) 
xTek ba √∫√ïQD\DGDNRPELQHRODUDNDPLORULGVSLURQRODNWRQ triamteren gibi idrar s√∂kt√ºr√ºc√º ila√ßlar 
(v√ºcutta potasyum birikmesi riski nedeniyle) 
xAnjiyotensin d√∂n√º √∫t√ºr√ºc√º enzim inhibit√∂rleri ve anjiotensin II resept√∂r antagonistle ri (v√ºcutta 
potasyum birikmesi riski nedeniyle) gibi tansiyon d√º √∫√ºr√ºc√º ila√ßlar 
xTakrolimus, siklosporin (v√ºcutta potasyum birikmesi riski nedeniyle) gibi ba √∑√ï√∫√ïNO√ïN sistemi 
EDVN√ïOD\√ïF√ïLODoODU 
xSalisilatlar (ate √∫d√º √∫¬ÅU¬ÅF¬Å RODUDN NXOODQ√ïODQ ELU LODo JUXEX barbit√ºratlar (havale GXUXPODU√ïQGD 
NXOODQ√ïODQ ELU LODo YH OLW\XP SVLNL\DWULN KDVWDO√ïNODUGD NXOODQ√ïOD Q ELU LODo gibi asidik ila√ßlar 
(LAFLEKS √∏=2/√∏)( -PLGUDU√ï DONDOL KDOH JHWLUGL√∑LQGHQ EX LODoODU√ïQ E|EUHNOHUGHQ DW√ïO √ïP√ï DUWDU 
HWNLOHULD]DO√ïU 
x%XUXQW√ïNDQ√ïNO√ï√∑√ïJLELGXUXPODUGDNXOODQ√ïODQVHPSDWRPLPHWLNLODoODU |UQHIHGULQ pseudoefedrin) 
ve i √∫WDK NHVLFL \D GD X\DU√ïF√ï VWLP¬ÅODQ RODUDN NXOODQ√ïODQ GHNVD PIHWDPLQ s√ºlfat, fenfluramin 
hidroklor√ºr gibi) alkali ila√ßlar (LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ LGUDU√ï 
alkali hale getirdi √∑LQGHQEXLODoODU√ïQE|EUHNOHUGHQDW√ïO√ïP√ïD]DO√ïUHWNLOHULDUWDU 
E√∑HU UHoHWHOL \D GD UHoHWHVL] KHUKDQJL ELU LODF√ï su anda kull DQ√ï\RUVDQ√ï] YH\D VRQ ]DPDQODUGD 
NXOODQG√ïQ√ï]LVHO¬ÅWIHQGRNWRUXQX]DYH\DHF]DF√ïQ√ï]DEXQODUKDNN√ïQGDELOJLYHULQL] 
3. LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ QDV√ïONXOODQ√ïO√ïU" 
8\JXQNXOODQ√ïPYHGR]X\JXODPDV√ïNO√ï√∑√ïLoLQWDOLPDWODU 
6L]LQEXLODFDKDQJLPLNWDUODUGDLKWL\DF√ïQ√ï]ROGX√∑ una ve size ne zaman uygulanaca √∑√ïQD doktorunuz 
karar verecektir. Buna ya √∫√ïQ√ï] Y¬ÅFXW D√∑√ïUO√ï√∑√ïQ√ï] YH EX LODF√ïQ VL]H X\JXODQPD nedenine g√∂re karar 
verecektir. Doktorunuz size ayr √ïELUWDYVL\HGHEXOXQPDG√ïNoDEXWDOLPDWODU√ïWDNLSHGLQL] 
√∏ODF√ïQ√ï]√ï]DPDQ√ïQGDDOPD\√ïXQXWPD\√ïQ√ï]                                                                                                 5                                                
    Doktorunuz LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ ile tedavinizin ne kadar s√ºrece √∑ini 
size bildirecektir. Tedaviyi erken kesmeyiniz √ß√ºnk√º istenen VRQXFXDODPD]V√ïQ√ï] 
Uygulama yolu ve metodu: 
7RSODUGDPDUODU√ïQ√ï]DX\JXQELUSODVWLNERUXVHWDUDF√ïO√ï√∑√ï\ODNXOODQ√ïO√ïU
Ya √∫O√ïODUGDNXOODQ√ïP 
Karaci √∑er, b√∂brek ya da kardiyak i √∫OHYOHUGHD]DOPDGDKDV√ïNJ|U¬ÅOG¬Å√∑ √ºnden ve birlikte ba √∫NDKDVWDO√ïN 
g√∂r√ºlme ya da ba √∫NDLODoNXOODQPDRODV√ïO√ï√∑√ïGDKDID]ODROGX√∑XQGDQJHQHORODUDN ya √∫O√ïODUGDGR]VHoLPL 
GLNNDWOHYHJHQHOGHGR]DUDO√ï√∑√ïQ√ïQP¬ÅPN¬ÅQRODQHQDOWWDNLV√ïQ√ïU√ïDO√ïQDUDN\DS√ïOP DO√ïG√ïU 
%XLODoE¬Å\¬ÅNRUDQGDE|EUHNOHU \ROX\ODDW√ïOG√ï√∑√ïQGDQE|EUHNL√∫ levlerinin bozuk oldu √∑X durumlarda 
LODF√ïQ ]DUDUO√ï HWNLOHULQLQ J|U¬ÅOPH ULVNL DUWDU <D√∫O√ïODU GD E|EUHN L√∫OHYOHULQLQ D]DOPDV√ï GDKD ID]OD 
oldu √∑undan doz se√ßiminde dikkatli olun PDO√ïYHWHGDYLV√ïUDV√ïQGDE|EUHN i√∫levleri izlenmelidir. 
g]HONXOODQ√ïPGXUXPODU√ï 
B√∂brek / Karaci √∑er yetmezli √∑i
%XLODoE¬Å\¬ÅNRUDQGDE|EUHNOHU \ROX\ODDW√ïOG√ï√∑√ïQGDQE|EUHNL√∫ levlerinin bozuk oldu √∑X durumlarda 
LODF√ïQ]DUDUO√ïHWNLOHULQLQJ|U¬ÅOPHULVNLDUWDU 
E√∑er LAFLEKS √∏=2/√∏)( -P
QLQHWNLVLQLQoRNJ¬ÅoO¬ÅYH\D]D\√ïIROGX √∑una dair bir izleniminiz var ise, 
GRNWRUXQX]YH\DHF]DF√ïQ√ï]LOHNRQX sunuz.
.XOODQPDQ√ï]JHUHNHQGHQGDKDID]OD/$)/(.6√∏=2/√∏)( -P  % 5 DEKSTROZ dg=(/7√∏6√∏ 
kXOODQG√ï\VDQ√ï] :
LAFLEKS √∏=2/√∏)( -P¬∂\LNXOODQPDQ√ï]JHUHNHQGHQID]ODV√ïQ√ïNXOODQP√ï √∫sDQ√ï]ELUGRNWRUYH\DHF]DF√ïLOH 
konu √∫unuz.
LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ ‚ÄônLNXOODQPD\√ïXQXWXUVDQ√ï] 
8QXWXODQGR]ODU√ïGHQJHOHPHNLoLQoLIWGR]DOPD\√ïQ√ï] 
LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ LOHWHGDYLVRQODQG√ïU√ïOG√ï√∑√ïQGDROX√∫ abilecek 
etkiler: 
%XOXQPDPDNWDG√ïU 
2ODV√ï\DQHWNLOHUQHOHUGLU" 
T√ºm ila√ßlar gibi, LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏¬∂ nin i√ßeri √∑inde bulunan 
PDGGHOHUHGX\DUO√ïRODQNL√∫LOHUGH\DQ etkiler olabilir. 
A√∫a√∑√ïGDNLOHUGHQ ELUL ROXUVD LAFLEKS √∏=2/√∏)( -P  '(.6752= dg=(/7√∏6√∏ ‚Äôni
NXOODQPD\√ïGXUGXUXQX]YH'(5+$/ doktorunuza ELOGLULQL]YH\DVL]HHQ\DN√ïQKDVWDQHQLQDFLO 
b√∂l√ºm√ºne ba √∫vurunuz: 
x√∏ODF√ïQX\JXODQG√ï√∑√ïE|OJHGHND√∫√ïQW√ïO√ïN√ï]DU√ïNO√ïNNDEDU√ïNO√ïN\DQPDKLVVL 
x6ROXQXPV√ïN√ïQW√ïV√ïK√ïU√ïOW√ïO√ïVROXQXPJ|√∑ √ºste a √∑U√ï                                                                                                 6                                                
    xV√ºcutta a √∫√ïU√ïV√ïFDNO√ïN\DGDVR√∑ ukluk hissi; 
xEllerde, ayaklarda, dudaklarda, y√ºzde veya t√ºm v√ºcutta √∫i√∫me; 
xBa √∫ G|QPHVLED\√ïOPDKLVVL 
x.DOSWHoDUS√ïQW√ï 
%XQODU√ïQKHSVLoRNFLGGL\DQHWNLOHUGLU 
E√∑er bunlardan biri sizde mevcut ise, sizin LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ 'ne
kar √∫√ïFLGGLDOHUMLQ iz var demektir. $FLOW√ïEELP¬ÅGDKDOH\HYH\DKDVWDQH\H\DW√ïU√ïOPDQ√ï]DJHUHNRODELOLU 
$\U√ïFDX\JXODPDGHYDPHGHUNHQY¬ÅFXGXQX]GDDWH√∫ , titreme gibi belirtiler olu √∫XUVDIHEULO reaksiyon) 
DERHAL doktorunuza bildiriniz; bu durumda doktor uygulamaya son vererek a cil W√ïEELP¬ÅGDKDOHGH 
bulunabilir. 
Bu √ßok ciddi yan etkilerin hepsi olduk√ßa seyrek g√∂r√ºl√ºr. 
A√∫a√∑√ïGDEHOLUWLOHQ\DQHWNLOHULQV√ïNO√ï√∑√ïELOLQPHPHNWHGLUHOGH ki veriler ile belirlenemeyecek kadar az 
hastada g√∂r√ºlebilir). 
A√∫a√∑√ïGDNLOHUGHQ KHUKDQJL ELULQL IDUN ederseniz, hemen doktorunuza bildiriniz veya size en 
\DN√ïQKDVWDQHQLQDFLOE|O¬ÅP¬ÅQHED√∫ vurunuz: 
x8\JXODPDQ√ïQ \DS√ïOG√ï√∑√ï \HUGH LOWLKDSODQPD X\JXODPDQ√ïQ \DS√ïOG√ï√∑√ï \HUGH Q ED√∫OD\DUDN 
WRSODUGDPDUODU√ïQ√ï]ER\XQFD\D\√ïODQVHUWOLNN√ï]DU√ïNO√ïN\DGD√∫ i√∫lik. 
xV√ºcudunuz GD YH\D NRO \D GD EDFDNODU√ïQ√ï]GD VX WRSODQPDV√ï |GHP VROXN DO√ïS YHUPH QL]GH 
zorla √∫PD \DWDUNHQ \D GD PHUGLYHQ o√ïNDUNHQ QHIHV DO√ïS Y ermede zorlanma (konjestif kalp 
yetmezli √∑i belirtileri) 
x.DOELQL]LQQRUPDOGHQK√ï]O√ï\DGD\DYD√∫ oDO√ï√∫PDV√ïJ|√∑¬ÅVWHV√ïN√ï√∫ ma hissi, g√∂ √∑√ºs a √∑U√ïV√ï 
x.RO \D GD EDFDNODU√ïQ√ï]GD KLVVL]OLN UHIOHNV ND\E√ï NDV \D GD VROXQXP IHOFL √∫XXUGD EXODQ√ïNO√ïN 
halsizlik, tansiyon d√º √∫mesi, kalbin ritminin b R]XOPDV√ï HOHNWURNDUGL\RJUDILGH anormallikler 
(Potasyum zehirlenmesine ba √∑O√ïEHOLUWLYH bulgular). 
x6√ïNQHIHVDO√ïSYHUPHPRUDUPD 
%XQODU√ïQKHSVLFLGGL\DQHWNLOHUGLU$FLOW√ïEELP¬ÅGDKDOHJHUHNHELOLU 
A√∫a√∑√ïGDNLOHUGHQKHUKDQJLELULQLIDUNHGHUVHQL]GRNWRUXQX]DV|\OH\LQL]  
x%XODQW√ïNXVPD 
x.DU√ïQD√∑U√ïV√ï 
x√∏shal. 
Bunlar LAFLEKS √∏=2/√∏)( -P% 5 DEKSTR 2=dg=(/7√∏6√∏ 'nin hafif yan etkileridir. 
E√∑HUEXNXOODQPDWDOLPDW√ïQGDEDKVLJHoPH\HQKHUKDQJLELU\DQHWNLLOHNDU√∫√ïOD√∫ √ïUVDQ√ï] doktorunuzu 
YH\DHF]DF√ïQ√ï]√ïELOJLOHQGLULQL] 
<DQHWNLOHULQUDSRUODQPDV√ï 
.XOODQPD WDOLPDW√ïQGD \HU DODQ YH\D DOPD\DQ KHUKDQJL ELU \DQ HWNL PH\GDQD JHOPHVL GXUXPXQGD 
KHNLPLQL] HF]DF√ïQ√ï] YH\D KHP√∫LUHQL] LOH NRQX√∫XQX] $\U√ïFD ND U√∫√ïOD√∫W√ï√∑√ïQ√ï] \DQ HWNLOHUL 
www.titck.gov.tr sitesinde yer alan ‚Äú √∏ODo<DQ(WNL%LOGLULPL¬¥LNRQXQDW√ïNOD\DUDN\DGD 
 QXPDUDO√ï \DQ HWNL ELOGLULP KDWW√ïQ√ï DUD\DUDN 7¬ÅUNL\H )DUPDNRYLML ODQV 0HUNH]L 7h)$0¬∂D                                                                                                 7                                                
    ELOGLULQL]0H\GDQDJHOHQ\DQHWNLOHULELOGLUHUHNNXOODQPDNWDROGX√∑XQX] LODF√ïQJ¬ÅYHQOLOL√∑LKDNN√ïQGD 
daha ID]ODELOJLHGLQLOPHVLQHNDWN√ïVD√∑ODP√ï√∫RODFDNV√ïQ√ï] 
5. LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏ ¬∂QLQVDNODQPDV√ï 
LAFLEKS √∏=2/√∏)( -P¬∂\L oRFXNODU√ïQ J|UHPH\HFH √∑i, eri √∫emeyece √∑i\HUOHUGH YH DPEDODM√ïQGD 
VDNOD\√ïQ√ï] 
¬É&¬∂QLQDOW√ïQGDNLRGDV√ïFDNO√ï√∑√ïQGDGR√∑UXGDQ √ï√∫√ïNDOPD\DQ\HUGHVDNOD\√ïQ√ï]
7HN NXOODQ√ïPO√ïNW√ïU .√ïVPHQ NXOODQ√ïOP√ï√∫ WRUEDODU VDNODQPDPDO√ï X\JXO DPDQ√ïQ \DS√ïOG√ï√∑√ï VD√∑O√ïN 
kurulu √∫XQXQW√ïEELDW√ïNSURVHG¬ÅUOHULQHX\JXQRODUDNLPKDHGLOPHOLGLU 
+HU ELU WRUEDQ√ïQ HWLNHWLQGH VRQ NXOODQPD WDULKL \D]PDNWDG√ïU %X tarih ge√ßmi √∫VH VL]H EX LODo 
verilmeyecektir. 
6RQNXOODQPDWDULKL\OHX\XPOXRODUDNNXOODQ√ïQ√ï] 
Ambalajdaki son kullanma tarihinden sonra LAFLEKS √∏=2/√∏)( -P'(.6752=dg=(/7√∏6√∏¬∂QL 
NXOODQPD\√ïQ√ï] 
 
6RQ NXOODQPD WDULKL JHoPL√∫ YH\D NXOODQ√ïOPD\DQ LODoODU√ï o|SH DWP D\√ïQ√ï] dHYUH YH √πHKLUFLOLN 
%DNDQO√ï√∑√ïQFDEHOLUOHQHQWRSODPDVLVWHPLQHYHULQL] 
Ruhsat sahibi: 063KDUPD√∏ODo6DQYH7LF$√π(UJHQH7HNLUGD√∑ 
Tel.: +090 282 655 55 05 
√úretim yeri: 063KDUPD√∏ODo6DQYH7LF$√π 
8OD√∫26%0DK'&DG(UJHQH26%1R(UJHQH7HNLUGD√∑ 
%XNXOODQPDWDOLPDW√ï 24.05.2017 WDULKLQGHRQD\ODQP√ï √∫W√ïU 
A√πA√∂IDAK √∏B√∏LG √∏LER BU √∏LACI UYGULAYACAK SA √∂LIK PERSONEL √∏ √∏√á√∏ND √∏R. 
Kullanma 7DOLPDW√ï 
.XOODQ√ïP|QFHVLo|]HOWLNRQWUROHGLOPHOLGLU 
8\JXODPDVWHULODSLURMHQVHWOHUOHLQWUDYHQ|]\ROGDQ\DS√ïO√ïU 
<DOQ√ï]FDEHUUDNSDUWLN¬ÅOV¬Å]YHDPEDODME¬ÅW¬ÅQO¬Å√∑¬ÅER]XOPDP√ï√∫ ¬ÅU¬ÅQOHU NXOODQ√ïOPDO√ïG√ïU 
Uygulama seti √ºr√ºne ili √∫tirildikten sonra uygulamaya HQN√ïVDV¬ÅUHGHED√∫ODQPDO√ïG√ïU 
.XOODQ√ïP|QFHVLQHNDGDUG√ï√∫ WRUEDV√ïQGDQo√ïNDU√ïOPDPDO√ïG√ïU 
Torbadaki rezid√ºel havaya ba √∑O√ïRODUDNPH\GDQDJHOHELOHFHNEL r hava embolisini √∂nlemek i√ßin, ba √∫ka 
LQI¬Å]\RQV√ïY√ïODU√ï\ODVHULED√∑ODQW√ï\DS√ïOPDPDO√ïG√ïU 24.05.2017                                                                                                8                                                
    √á√∂zelti steril uyg XODPD VHWL DUDF√ïO√ï√∑√ï\OD DVHSWLN WHNQLN NXOODQ√ïODUDN X\JXODQPDO√ï G√ïU 6LVWHPH hava 
JLUPHPHVLLoLQX\JXODPDVHWLQGHQNXOODQ√ïP|QFHVLV√ïY√ïJHoLULOPHOLGLU 
Ek ila√ßlar, aseptik ko √∫ullarda bir i √∑QH\DUG√ïP√ïLOHLQI¬Å]\RQ|QFHVLYHV√ïUDV√ïQGDNDW√ïODELOLU Olu √∫an son 
¬ÅU¬ÅQ¬ÅQL]RWRQLVLWHVLSDUHQWHUDOX\JXODPD\DS√ïOPDGDQ|QFHEHOLUOHQPL√∫ ROPDO√ïG√ï U 
Hastaya uygulamadan √∂nce eklenmi √∫ LODF√ïQ o|]HOWL\OH W¬ÅP¬Å\OH NDU√ï√∫P√ï√∫ ROPDV√ï JHUHNOLGLU (N ila√ß 
LoHUHQ o|]HOWLOHU LODo HNOHQPHVLQGHQ KHPHQ VRQUD NXOODQ√ïOPDO√ïG√ïU GDKD VRQUD NXOODQ√ïOPDN √ºzere 
VDNODQPDPDO√ïG√ïU 
d|]HOWL\HHNLODoNDW√ïOPDV√ï\DGD\DQO√ï√∫ uygulama tekni √∑i, √ºr√ºne pirojen kontaminasyonuna ba √∑O√ïDWH√∫
reaksiyonuna neden olabilir. Advers reaksiyon g√∂r√ºlmesi durumunda inf√ºzy ona hemen son 
verilmelidir. 
7HNNXOODQ√ïPO√ïNW√ïU 
.√ïVPHQ NXOODQ√ïOP√ï√∫ o|]HOWLOHU VDNODQPDPDO√ïG√ïU .√ïVPHQ NXOODQ√ïOP√ï√∫ KHUKDQJL ELU E|O¬ÅP¬Å 
DW√ïOPDO√ïG√ïU.√ïVPHQNXOODQ√ïOP√ï√∫ WRUEDODU√ï\HQLGHQKDVWD\DX\JXODQDQVLVW HPOHUHED√∑ODPD\√ïQ√ï] 
A√ßmak i√ßin: 
 '√ï√∫ DPEDODM√ïQ VD√∑ODPO√ï√∑√ïQ√ï YH V√ï]√ïQW√ï ROXS ROPDG√ï√∑√ïQ√ï NRQWURO ediniz; ambalaj hasar g√∂rd√ºyse 
NXOODQPD\√ïQ√ï] 
.RUX\XFXG√ï√∫ DPEDODM√ï\√ïUWDUDNDo√ïQ√ï] 
.RUX\XFXDPEDODMLoLQGHNLWRUEDQ√ïQVD√∑ODPROXSROPDG√ï√∑√ïQ√ïV√ïNDUDNNRQWUROHGLQL] 
7RUEDLoLQGHNLo|]HOWLQLQEHUUDNO√ï√∑√ïQ√ïYHLoLQGH\DEDQF√ïPDGGHLoHUPHGL√∑ ini kontrol ediniz. 
8\JXODPDKD]√ïUO√ïNODU√ï 
7RUED\√ïDV√ïQ√ï] 
2. Uygulama ucundaki koruyucu kapa √∑√ïo√ïNDU√ïQ√ï] 
 8\JXODPD VHWLQLQ VSD\N√ïQ√ï X\JXODPD XFXQD V√ïN√ïFD EDW√ïU√ïQ√ï] d|]HOWL QLQ VHW Lo inden ge√ßirilerek 
KDVWD\DX\JXODQPDV√ïLoLQVHWLQNXOODQ√ïPWDOLPDW√ïQDX\XOPDO√ïG√ïU 
Ek ila√ß ekleme: 
Dikkat: T√ºm parenteral √ß√∂zeltilerde oldu √∑u gibi, √ºr√ºne eklenecek t√ºm maddeler √ºr√ºnle ge√ßimli 
ROPDO√ïG√ïUhU¬ÅQHHNOHPH\DS√ïODFDNVDKDVWD\DX\JXODPDGDQ|QFHVRQND U√ï√∫√ïP√ïQGD ge√ßimlilik kontrol 
edilmelidir. 
Uygulama √∂ncesi ila√ß ekleme 
1. √∏la√ß uygulama ucu dezenfekte edilir. 
2. Eklenecek ila√ß 19-  JDXJH NDO√ïQO√ï√∑√ïQGDNL ELU L√∑ nesi olan enjekt√∂rle ila√ß uygulama ucundan 
X\JXODQ√ïU 
 d|]HOWL YH LoLQH HNOHQHQ LODo L\LFH NDU√ï√∫W√ïU√ïO√ïU 3RWDV\XP NO RU¬ÅU JLEL \R√∑XQ LODoODUGD WRUEDQ√ïQ 
X\JXODPDo√ïN√ï√∫√ïQD\XNDU√ïSR]LV\RQGD\NHQKDILIoHYXUXODUDNNDU√ï√∫PDV√ïVD√∑ ODQ√ïU 
Dikkat :√∏oLQHHNLODoX\JXODQP√ï√∫ torbalar √ïsakla PD\√ïQ√ï] 
8\JXODPDV√ïUDV√ïQGDLODoHNOHPH 
6HWLQNOHPSLNDSDW√ïO√ïU                                                                                                 9                                                
    2. √∏la√ß uygulama ucu dezenfekte edilir. 
3. Eklenecek ila√ß 19-22 gauge NDO√ïQO√ï√∑√ïQGDNL ELU L√∑ nesi olan enjekt√∂rle ila√ß uygulama ucundan 
X\JXODQ√ïU 
7RUEDDVN√ïV√ïQGDQo√ïNDU√ïO√ïUYHWHUVoHYULOLU 
%XSR]LV\RQGD\NHQWRUEDQ√ïQX\JXODPDo√ïN√ï√∫√ïYHHQMHNVL\RQJLUL√∫ ine hafif√ße vurularak √ß√∂zelti ve ek 
LODF√ïQNDU√ï√∫PDV√ïVD√∑ODQ√ïU 
6. TRUED\√ïHVNLNRQXPXQDJHWLUHUHNNOHPSDo√ïO√ïUYHX\JXODPD\DGHYDPHGLOLU 